| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |